Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Tofacitinib (CP-690,550) in Asian Subjects with Moderate to Severe Chronic Plaque Psoriasis
NCT01815424Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of tofacitinib in plaque psoriasis, sponsored by Pfizer. Started Dec 2013; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01815424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01815424.